PPAR-gamma agonist rosiglitazone stops the progressive dopaminergic degeneration induced by chronic MPTP in mice

被引：0
作者：
Carta, A. [1 ]
Frau, L. [1 ]
机构：
[1] Univ Cagliari, Toxicol, Cagliari, Italy
来源：
PARKINSONISM & RELATED DISORDERS | 2009年 / 15卷
关键词：
D O I：
10.1016/S1353-8020(09)70473-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2.122
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
[21]   Engeletin ameliorates sevoflurane-induced cognitive impairment by activating PPAR-gamma in neonatal mice [J].
Jiang, Su ;
Xiong, Ying ;
Wang, Xinyan .
NEUROPATHOLOGY, 2023, 43 (06) :431-440
[22]   Damage to vascular endothelial cells by high insulin levels is associated with increased expression of ChemR23, and attenuated by PPAR-gamma agonist, rosiglitazone [J].
Hao, Fei ;
Mu, Jia-wei ;
Zhang, Hui-juan ;
Kuang, Hong-yu ;
Yu, Qiu-xia ;
Bai, Meng-meng ;
Meng, Ping .
NEUROENDOCRINOLOGY LETTERS, 2015, 36 (01) :59-66
[23]   Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice [J].
Parain, K ;
Marchand, V ;
Dumery, B ;
Hirsch, E .
BRAIN RESEARCH, 2001, 890 (02) :347-350
[24]   Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions [J].
Gibrat, Claire ;
Saint-Pierre, Martine ;
Bousquet, Melanie ;
Levesque, Daniel ;
Rouillard, Claude ;
Cicchetti, Francesca .
JOURNAL OF NEUROCHEMISTRY, 2009, 109 (05) :1469-1482
[25]   FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone [J].
Stechschulte, Lance A. ;
Qiu, Bin ;
Warrier, Manya ;
Hinds, Terry D., Jr. ;
Zhang, Man ;
Gu, Hao ;
Xu, Yuxue ;
Khuder, Saja S. ;
Russo, Lucia ;
Najjar, Sonia M. ;
Lecka-Czernik, Beata ;
Yong, Weidong ;
Sanchez, Edwin R. .
ENDOCRINOLOGY, 2016, 157 (10) :3888-3900
[26]   Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers [J].
Lubet, Ronald A. ;
Fischer, Susan M. ;
Steele, Vernon E. ;
Juliana, M. Margaret ;
Desmond, Renee' ;
Grubbs, Clinton J. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (10) :2254-2259
[27]   The PPAR Gamma Agonist Rosiglitazone Protects Against Wnt Signaling In Hyperoxia-Induced Neonatal Rat Lung Injury [J].
Dasgupta, Chiranjib ;
Wang, Ying ;
Sakurai, Reiko ;
Torday, John S. ;
Rehan, Virender .
FASEB JOURNAL, 2008, 22
[28]   Platelet-activating factor receptor knockout mice are protected from MPTP-induced dopaminergic degeneration [J].
Kim, Beom Keun ;
Shin, Eun-Joo ;
Kim, Hyoung-Chun ;
Chung, Yoon Hee ;
Dang, Duy-Khanh ;
Jung, Bae-Dong ;
Park, Dae-Hun ;
Wie, Myung Bok ;
Kim, Won-Ki ;
Shimizu, Takao ;
Nabeshima, Toshitaka ;
Jeong, Ji Hoon .
NEUROCHEMISTRY INTERNATIONAL, 2013, 63 (03) :121-132
[29]   PPAR-Gamma Agonist-Induced Telomerase Activation in Endothelial Cells and Endothelial Progenitor Cells is Mediated by the Survival Kinase Akt [J].
Werner, Christian ;
Bakogiannis, Constantinos ;
Boehm, Michael ;
Laufs, Ulrich .
CIRCULATION, 2011, 124 (21)
[30]   Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats [J].
Lee, Eun Young ;
Lee, Jeong Eun ;
Park, Jae Hyeon ;
Shin, In Chul ;
Koh, Hyun Chul .
TOXICOLOGY LETTERS, 2012, 213 (03) :332-344
12345